VQK Technology Officially Lists On The Beijing Stock Exchange, Marking A New Chapter For Cosmetic Peptide Ingredient Innovation

Jul 31, 2026

Leave a message

Michael Brown
Michael Brown
Michael is an international sales representative of Shaanxi Medibridge Biotech. He is proficient in multiple languages and has a wide network in the global pharmaceutical, health and beauty, and scientific research industries. He is committed to promoting the company's products to the international market.
news-1536-1024

A Milestone Listing Reflecting Long-Term Technical Commitment

On July 27, Shenzhen-based VQK Technology officially debuted on the Beijing Stock Exchange under stock code 920176, with an issue price of CNY 22.16 per share. Market reports described the listing as a milestone for the peptide raw-material segment, with the company widely referred to as China's first listed "peptide ingredient" enterprise. The stock's first-day market performance also attracted considerable attention, underscoring investor interest in companies with differentiated technology platforms and specialized ingredient capabilities.

 

Building Innovation from the Ingredient Source

Unlike many companies that focus primarily on formulation application and finished-product adaptation, VQK Technology has chosen to build innovation from the raw-material level. Public coverage has characterized the company as a technology-driven enterprise deeply engaged in active peptide development, with a business system centered on skin-active peptide ingredients. This source-level innovation model reflects a strategic belief that stronger upstream scientific capability can create more durable value for customers, partners, and the wider cosmetics supply chain.

news-1536-1024

 

news-1536-1024

Bringing a Pharmaceutical R&D Mindset into Cosmetic Peptides

One of the most distinctive aspects of VQK Technology's positioning is its emphasis on systematic peptide research and development. Media reports note that the company has been among the earlier domestic suppliers to conduct structured studies on peptide skincare applications, while building solution coverage across anti-aging, brightening, acne care, repair, and other use scenarios. This approach suggests an increasingly higher entry barrier for peptide ingredient development, where screening, validation, and scientific rigor matter as much as market responsiveness.

 

Signaling a Broader Upgrade in the Beauty Ingredient Industry

VQK Technology's listing is significant not only for the company itself, but also for what it represents for the broader beauty ingredient market. As brands seek more science-backed actives and clearer differentiation, upstream ingredient innovation is becoming more central to long-term competitiveness. The company's public-market debut sends a strong signal that peptide science, technical depth, and scalable raw-material innovation are gaining recognition as key drivers of future growth in the cosmetics industry.

news-1536-1024

 

news-1536-1024

Looking Ahead

With its Beijing Stock Exchange debut, VQK Technology enters a new stage of development with greater visibility and broader market attention. The company's path reflects a wider trend: cosmetic ingredient innovation is moving upstream, and peptide raw materials are becoming a more strategically important category. As the sector continues to evolve, companies that combine deep research capability with application value may be best positioned to shape the next phase of high-quality industry growth.

 

 

Send Inquiry